Stanford's new cell therapy cures type 1 diabetes in mice
SMRTR summary
Stanford scientists successfully prevented and reversed type 1 diabetes in mice by transplanting blood stem cells and pancreatic islet cells from mismatched donors, creating a hybrid immune system that stops autoimmune attacks on insulin-producing cells. The breakthrough eliminates the need for immunosuppressive drugs or insulin injections.
SMRTR provides this summary for quick context. The original article belongs to Science Daily.
Read the original article